Comment on: “Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: Data from the BIOBADAGUAY registry” Sarah Aijaz, Raveen Muzaffer

Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit José María Alvaro-Gracia, Miguel Arredondo, Esteban Daudén, Virginia Meca-Lallana, Alberto Morell, Javier P. Gisbert, Guillermo Fernández-Jiménez, Rosario García de Vicuña, Francisco Javier Aspa, María Jesús García de Yébenes, Loreto Carmona

Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: A case control study Pilar Espiño-Lorenzo, Sara Manrique-Arija, Inmaculada Ureña, Francisco Gabriel Jiménez-Núñez, María López-Lasanta, Carmen María Romero-Barco, María Angeles Belmonte-López, María Victoria Irigoyen, Antonio Fernández-Nebro